Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
12,759,251
-
Share change
-
-92,629
-
Total reported value
-
$22,964,294
-
Put/Call ratio
-
55%
-
Price per share
-
$1.80
-
Number of holders
-
29
-
Value change
-
-$366,691
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q4 2024
As of 31 Dec 2024,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,759,251 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, B Group, Inc., Capital International Investors, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, MILLENNIUM MANAGEMENT LLC, BAILLIE GIFFORD & CO, UBS Group AG, MACQUARIE GROUP LTD, MORGAN STANLEY, and LPL Financial LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.